Quinnova Pharmaceuticals
Latest round
- Series B
Last raised
- Oct 2009
Total raised
- $30M
Investors
- 5
About Quinnova Pharmaceuticals
Quinnova Pharmaceuticals Inc.Founded in 2003, Quinnova Pharmaceuticals Inc. specializes in performance-enhancing supplements. In December 2013, the company was acquired by Everett Laboratories. The firm operates out of the United States, focusing primarily on the North American and European markets.Quinnova Pharmaceuticals specializes in the development and distribution of performance-enhancing supplements, including SARMs (Selective Androgen Receptor Modulators), peptides, and nootropics. Their core products support muscle growth, fat loss, and cognitive enhancement, catering to bodybuilders, athletes, and individuals seeking to optimize their performance.Quinnova Pharmaceuticals generates revenue through direct sales of its supplement products, primarily targeting individual consumers and fitness enthusiasts. Sales are facilitated through their online platform, offering products like MK-677 and CJC 1295 Ipamorelin. The company also engages in partnerships with retailers.Quinnova Pharmaceuticals plans to expand its product line and market reach. Specific upcoming products and their release dates have not been disclosed, but the focus will remain on enhancing their offerings in existing territories, particularly North America and Europe.
Who invested in Quinnova Pharmaceuticals
5 investors across 2 rounds
See all investors in Quinnova Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Quinnova Pharmaceuticals
Who invested in Quinnova Pharmaceuticals?
Quinnova Pharmaceuticals has 5 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Quinnova Pharmaceuticals raised?
Quinnova Pharmaceuticals has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Quinnova Pharmaceuticals last raise money?
Quinnova Pharmaceuticals's most recent round on record is a Series B, in Oct 2009.
What does Quinnova Pharmaceuticals do?
Quinnova Pharmaceuticals is a pharmaceuticals company.
Where is Quinnova Pharmaceuticals headquartered?
Quinnova Pharmaceuticals is headquartered in US.
Which VCs invest in companies like Quinnova Pharmaceuticals?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Quinnova Pharmaceuticals's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series B
Raising like Quinnova Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.